CN104001026A - Medicine for treating myocardial ischemia - Google Patents
Medicine for treating myocardial ischemia Download PDFInfo
- Publication number
- CN104001026A CN104001026A CN201410270920.5A CN201410270920A CN104001026A CN 104001026 A CN104001026 A CN 104001026A CN 201410270920 A CN201410270920 A CN 201410270920A CN 104001026 A CN104001026 A CN 104001026A
- Authority
- CN
- China
- Prior art keywords
- parts
- myocardial ischemia
- medicine
- treating
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to medicine for treating myocardial ischemia. The medicine for treating the myocardial ischemia is composed of the following raw materials, by mass, 3-5 parts of pseudo-ginseng, 1-3 parts of radix polygonati officinalis, 2-4 parts of common andrographis herb, 1-3 parts of peach kernels, 3-5 parts of rhodiola rosea, 3-5 parts of folium ginkgo and 3-5 parts of the root of red-rooted salvia. The medicine for treating the myocardial ischemia is pure traditional Chinese medicine preparations, has no toxic or side effects, and is obvious in treatment effect on the myocardial ischemia.
Description
Technical field
The invention belongs to biomedicine field, be specifically related to a kind of medicine for the treatment of myocardial ischemia.
Background technology
Myocardial ischemia refers to that the hemoperfusion of heart reduces, and causes the oxygen supply of heart to reduce, and energy metabolism of myocardial is undesired, can not support a kind of pathological state of the normal work of heart.The traditional Chinese medical science is referred to as " obstruction of qi in the chest and cardialgia ", " precordial pain with cold limbs ".Myocardial ischemia is clinical taking uncomfortable in chest, precordialgia as principal character.
The fundamental cause that myocardial ischemia occurs is that the oxygen delivery capacity of coronary flow is not enough to meet the demand of cardiac muscle to oxygen, and myocardial ischemia metabolite lactic acid, histamine and K+ accumulate, and stimulate sympathetic nerve to import maincenter into.Can be divided into again the angina pectoris of Secondary cases arteriosclerotic heart disease and the constitutional angina pectoris that coronary spasm, coronary artery thrombus cause by the mechanism of its morbidity.
Cause the cause of disease, the pathological process complexity of myocardial ischemia, at present to its treatment taking conservative medication as main.The key of the Drug therapy of myocardial ischemia is to make the supply of oxygen and consumption again reach balance, and its treatment means mainly can be divided into two classes, and one is to reduce myocardial oxygen consumption, and another kind is to improve coronary flow.At present clinically the medicaments for resisting myocardial ischemia of application have multiple, conventional nitrate esters, beta-blocker and the myocardial metabolism medicine etc. of comprising.
In recent years, China has carried out extensive and deep research to the Chinese herbal medicine resisting myocardial ischemia, excavate and improved motherland's Chinese medicine and pharmacy, as the Radix Salviae Miltiorrhizae from drug for invigorating blood circulation and eliminating stasis, Radix Notoginseng, Rhizoma Chuanxiong, Folium Ginkgo, Radix Ilicis Pubescentis, the Radix Puerariae of excavating from diaphoretic medicine, the Radix Ginseng of excavating from tonic, the Ilex purpurea Hassk.[I.chinensis Sims of excavating from heat and toxic materials clearing away medicine etc., show certain function of resisting myocardial ischemia through preliminary study.
Summary of the invention
The problem of comprehensive state of the art and existence, the object of the present invention is to provide a kind of medicine for the treatment of myocardial ischemia, and the present invention is pure Chinese medicinal preparation, without any side effects, treatment myocardial ischemia successful.
For achieving the above object, the present invention is made up of the raw material of following mass ratio: Radix Notoginseng 3-5 part, Rhizoma Polygonati Odorati 1-3 part, Herba Andrographis 2-4 part, Semen Persicae 1-3 part, Radix Rhodiolae 3-5 part, Folium Ginkgo 3-5 part, Radix Salviae Miltiorrhizae 3-5 part.
The medicine for the treatment of myocardial ischemia of the present invention, can select decoction dosage form, and its preparation method decocts for adding 5-10 times of water, takes night and morning.
The present invention is basic upper mentioned component, also can add suitable pharmaceutic adjuvant, is prepared into other peroral dosage forms, as granule, tablet, capsule, oral liquid etc. with conventional method of Chinese medicinal.
Detailed description of the invention
The medicine that embodiment 1. the present invention treat myocardial ischemia is made up of the raw material of following mass ratio: 5 parts of Radix Notoginseng, 1 part of Rhizoma Polygonati Odorati, 2 parts of Herba Andrographis, 3 parts, Semen Persicae, 3 parts of Radix Rhodiolaes, 3 parts of Folium Ginkgos, 5 parts of Radix Salviae Miltiorrhizaes, and add 5 times of decoctings and boil, sooner or later respectively take 1 time.
The medicine that embodiment 2. the present invention treat myocardial ischemia is made up of the raw material of following mass ratio: 3 parts of Radix Notoginseng, 3 parts of Rhizoma Polygonati Odorati, 4 parts of Herba Andrographis, 1 part, Semen Persicae, 5 parts of Radix Rhodiolaes, 5 parts of Folium Ginkgos, 3 parts of Radix Salviae Miltiorrhizaes, and add 9 times of decoctings and boil, sooner or later respectively take 1 time.
Embodiment 3. model cases: Wang, 61 years old, suffer from myocardial ischemia more than 3 years, usually uncomfortable in chest, cardiopalmus, breathe hard, take this product 1 week afterwards symptom be clearly better.
Claims (2)
1. the medicine for the treatment of myocardial ischemia, is made up of the raw material of following mass ratio: Radix Notoginseng 3-5 part, Rhizoma Polygonati Odorati 1-3 part, Herba Andrographis 2-4 part, Semen Persicae 1-3 part, Radix Rhodiolae 3-5 part, Folium Ginkgo 3-5 part, Radix Salviae Miltiorrhizae 3-5 part.
2. the medicine for the treatment of according to claim 1 myocardial ischemia, is characterized in that: described form of administration is peroral dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410270920.5A CN104001026A (en) | 2014-06-17 | 2014-06-17 | Medicine for treating myocardial ischemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410270920.5A CN104001026A (en) | 2014-06-17 | 2014-06-17 | Medicine for treating myocardial ischemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104001026A true CN104001026A (en) | 2014-08-27 |
Family
ID=51362114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410270920.5A Pending CN104001026A (en) | 2014-06-17 | 2014-06-17 | Medicine for treating myocardial ischemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104001026A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055513A (en) * | 2015-07-22 | 2015-11-18 | 中国中医科学院中药研究所 | Effect of Shenlian extract in preventing and treating myocardial ischemic diseases and haze caused myocardial ischemic diseases |
| CN106563069A (en) * | 2015-10-09 | 2017-04-19 | 李道远 | Drug for treating cardiovascular diseases |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005137210A (en) * | 2003-11-04 | 2005-06-02 | Hino Shokai:Kk | Composition comprising concoction of tea and peucedanum japonicum thunb. or extract from the concoction |
| CN101167838A (en) * | 2006-11-06 | 2008-04-30 | 张文武 | Traditional Chinese medicinal preparation for treating coronary heart disease and angina pectoris and its preparing process |
| CN103381260A (en) * | 2013-05-23 | 2013-11-06 | 太仓市胜舟生物技术有限公司 | Application of traditional Chinese medicinal composition in treating coronary heart disease |
-
2014
- 2014-06-17 CN CN201410270920.5A patent/CN104001026A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005137210A (en) * | 2003-11-04 | 2005-06-02 | Hino Shokai:Kk | Composition comprising concoction of tea and peucedanum japonicum thunb. or extract from the concoction |
| CN101167838A (en) * | 2006-11-06 | 2008-04-30 | 张文武 | Traditional Chinese medicinal preparation for treating coronary heart disease and angina pectoris and its preparing process |
| CN103381260A (en) * | 2013-05-23 | 2013-11-06 | 太仓市胜舟生物技术有限公司 | Application of traditional Chinese medicinal composition in treating coronary heart disease |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055513A (en) * | 2015-07-22 | 2015-11-18 | 中国中医科学院中药研究所 | Effect of Shenlian extract in preventing and treating myocardial ischemic diseases and haze caused myocardial ischemic diseases |
| CN106563069A (en) * | 2015-10-09 | 2017-04-19 | 李道远 | Drug for treating cardiovascular diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386008A (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN101708237B (en) | Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN101961386A (en) | Traditional Chinese medicine for treating diabetic skin pruritus | |
| CN104001026A (en) | Medicine for treating myocardial ischemia | |
| CN104000871A (en) | Drug for treating myocardial ischemia | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN105435196A (en) | Externally-applied traditional Chinese medicine ointment for treating qi stagnation and blood stasis coronary angina pectoris with chronic gastritis and preparation method thereof | |
| CN100540025C (en) | Treat Parkinsonian Chinese medicine preparation and preparation method thereof | |
| CN104474015A (en) | Medicine for lowering blood pressure and blood fat and preparation method of medicine | |
| CN103989723A (en) | Drug for treating myocardial ischemia | |
| CN103127413B (en) | Pharmaceutical preparation for treating coronary diseases | |
| CN104042735A (en) | Medicament for alleviating myocardial ischemia | |
| CN104000884A (en) | Pharmaceutical composition for relieving myocardial ischemia | |
| CN103989758A (en) | Pharmaceutical composition for relieving myocardial ischemia | |
| CN101612233B (en) | Chinese medicine preparation for detumescence and analgesia | |
| CN102940833B (en) | Traditional Chinese medicine composition for treating coronary heart disease and preparation method thereof | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101249250A (en) | Medicinal liquor preparations for curing stagnation and blood stasis chest stuffiness and pain | |
| CN105079394A (en) | Pharmaceutic preparation for treating arrhythmia | |
| CN105213774A (en) | A kind of pharmaceutical composition for the treatment of chronic heart failure | |
| CN102716434B (en) | Medicine for oral use for treating hypotension | |
| CN103285163A (en) | Formula of traditional Chinese medicine for treating diabetes with other complications | |
| CN104001017A (en) | Traditional Chinese medicine for treating stenocardia catabasis used in fuming and washing foot bath |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140827 |
|
| WD01 | Invention patent application deemed withdrawn after publication |